TOP TIERMARKET NEWSWIRE
News & sentiment

OPPENHEIMER HLDGS IN A (OPY) — News & AI sentiment

OPPENHEIMER HLDGS IN A (OPY) news roundup. 7 stories in the last 24 hours, 47 in the past week, 146 over 30 days. Average 24-hour sentiment is 50.9/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
7
avg sentiment 50.9/100
7d stories
47
avg sentiment 52.8/100
30d stories
146
avg sentiment 55.6/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

OPY news in the last 24 hours, 7 days, 30 days and 90 days

How much OPY coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowOPY storiesAvg AI sentimentRead
Last 24 hours750.9/100OPY headlines →
Last 7 days4752.8/100OPY headlines →
Last 30 days14655.6/100OPY headlines →
Last 90 days33254.9/100OPY headlines →

Latest stories on OPY

12h ago
17h ago
Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal
Investing.com Analyst Ratings56 · neutralanalyst
18h ago
21h ago
21h ago
Oppenheimer reiterates Corteva stock rating amid spinoff focus
Investing.com Analyst Ratings56 · neutralanalyst
21h ago
1d ago
1d ago
2d ago
2d ago
2d ago
2d ago
2d ago
2d ago
Oppenheimer initiates Inova Technology stock rating at Outperform
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
2d ago
Oppenheimer initiates Viatris stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Oppenheimer initiates Vanda Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating
Investing.com Analyst Ratings50 · neutralanalyst
2d ago
Oppenheimer initiates Amneal Pharmaceuticals stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Oppenheimer initiates CorMedix stock coverage with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
Oppenheimer initiates Pacira stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
2d ago
2d ago
2d ago
Open OPY in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →